Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZ) Capital Leases (2021 - 2024)

Core Scientific's Capital Leases history spans 5 years, with the latest figure at $844000.0 for Q4 2025.

  • For Q4 2025, Capital Leases rose 28033.33% year-over-year to $844000.0; the TTM value through Dec 2025 reached $844000.0, up 28033.33%, while the annual FY2025 figure was $844000.0, 28033.33% up from the prior year.
  • Capital Leases for Q4 2025 was $844000.0 at Core Scientific, up from $3000.0 in the prior quarter.
  • Across five years, Capital Leases topped out at $62.1 million in Q4 2021 and bottomed at $3000.0 in Q4 2024.
  • The 5-year median for Capital Leases is $35.7 million (2023), against an average of $31.0 million.
  • The largest annual shift saw Capital Leases crashed 99.99% in 2024 before it skyrocketed 28033.33% in 2025.
  • A 5-year view of Capital Leases shows it stood at $62.1 million in 2021, then dropped by 9.09% to $56.5 million in 2022, then tumbled by 36.73% to $35.7 million in 2023, then plummeted by 99.99% to $3000.0 in 2024, then surged by 28033.33% to $844000.0 in 2025.
  • Per Business Quant, the three most recent readings for CORZ's Capital Leases are $844000.0 (Q4 2025), $3000.0 (Q4 2024), and $35.7 million (Q4 2023).